Patients first
WWARN Antimalarial Quality Module Head, Paul Newton, heads a call by leading scientists to put public health, rather than intellectual property, considerations first in defining poor quality medicines in efforts to improve the quality of medicines in developing countries. An essay published in the December 2011 issue of PLoS Medicine [link] examines how confusion over the definition of poor quality medicines is causing unacceptable delays in tackling this major public health issue.
- Login or register to post comments
-
Printer-friendly version